Dr. George F. Corrent, MD, PhD

Dr. Corrent practices at Quigley Eye Specialists in Naples, Florida.

Dr. Corrent's NPI, 1639156086, was assigned on December 28, 2005. Dr. Corrent graduated from McGovern Medical School in 1983. Dr. Corrent holds Florida license ME50295.

Dr. Corrent's primary practice is Quigley Eye Specialists, at 15215 Collier Blvd, Naples, FL 34119 in Collier County. The practice phone is (239) 466-2020.

Dr. Corrent's primary practice is Quigley Eye Specialists in Naples, Florida. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Corrent to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Corrent practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Corrent's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Corrent is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Corrent's licenses on file in 4 states: Florida, North Carolina, Ohio and Texas.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation and eyelid inflammation among the conditions Dr. Corrent treats.

CMS data shows 821 Medicare services from Dr. Corrent across 11 procedure codes in 2024, for 385 Medicare patients. Medicare paid $65,587 for them.

CMS counts 385 Medicare patients who saw Dr. Corrent in 2024. The largest group is 75 to 84, with 201 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.19, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Corrent's median patient age at 74, with 56% women.

In 2024, Dr. Corrent wrote 858 Medicare Part D claims for 309 patients. 59% of them were for generic drugs. CMS names the drug for 756 of them, across 11 drugs with 11 or more claims each, at $26,080 in total drug cost. In 2023, CMS named 1,348 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Corrent for performance year 2024, reported as part of a group. Dr. Corrent accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 19 procedures of cataract surgery by Dr. Corrent, more than 43% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. Corrent. The most frequent topics are AIDS-Related Opportunistic Infections, Cornea and Visual Acuity. Dr. Corrent has published most often in Am J Ophthalmol. Dr. Corrent's most frequent co-authors are William W. Culbertson, MD, Thomas E. Johnson, MD and Jan W. Kronish, MD.

CMS Open Payments shows 136 general payments to Dr. Corrent from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Bausch Health Americas, Inc. paid the most, $819.

Dmand AI lists 1 award for Dr. Corrent, most recently Castle Connolly Best Doctors in 2020.

Dr. Corrent graduated from McGovern Medical School in 1983.

Dr. Corrent is in network with 13 carriers, including Aetna, Excellus BlueCross BlueShield and Elevance. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.